GlassScriptPhysician profile
Alisha Ellen Ludwig
NPI 1932443199
$1,331.02
in general payments reported to CMS, 2019-2025
13 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $175 · 2021: $166 · 2022: $96.47 · 2023: $392 · 2024: $218 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $358.12 | 2019-2022 | |
| Vaporox, INC. | $166.87 | 2023 | Vht-200 Wound Treatment System |
| Smith+Nephew, INC. | $157.12 | 2019-2023 | Collagenase Santyl, Regranex |
| Convatec INC. | $149.76 | 2023-2024 | |
| Organogenesis INC. | $132.40 | 2022-2025 | Puraply, Novachor, Puraply Wound Matrix |
| Ani Pharmaceuticals, INC. | $122.45 | 2025 | Purified Cortrophin Gel |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $96.36 | 2023 | Jublia |
| Nevro Corp. | $47.04 | 2021-2022 | |
| Averitas Pharma INC. | $30.57 | 2023 | Qutenza |
| Tactile Systems Technology INC | $23.85 | 2024 | Entre Plus, Flexitouch Plus |
| Bioventus LLC | $21.22 | 2025 | Exogen Ultrasound Bone Healing System |
| Grt US Holding, INC. | $12.80 | 2022 | |
| Wright Medical Technology, INC. | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Ludwig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.